In preclinical studies, researchers showed that PD-L1 expression was increased following exposure to ionizing radiation and that the administration of anti-PD-L1 antibody synergized with radiation treatment to reduce suppressor cells localized to the tumor environment. This evidence concerns the gene CD274 and neoplasm.